<?xml version="1.0" encoding="UTF-8"?>
<p>A new respiratory infectious disease was reported in Wuhan, Hubei Province of China, around December 2019 (
 <xref rid="B1" ref-type="bibr">1</xref>, 
 <xref rid="B2" ref-type="bibr">2</xref>). The outbreak at the initial stage was linked to a seafood market with a possibility of animal transmission. In due course of time, human to human infection began that spread across the globe, and the disease was called as COVID-19 (Coronavirus disease 19). The newly emerged virus was named as SARS Corona virus-2 (SARS-CoV-2; 
 <xref ref-type="fig" rid="F1">Figure 1</xref>), based on the etiology and symptoms, which is closely associated with SARS-CoV identified in the year 2002 in China (
 <xref rid="B3" ref-type="bibr">3</xref>). The epidemic of COVID-19 has been declared as a pandemic by the WHO on 30th January 2020, which affected the population across the globe to the worst possible extent (
 <xref rid="B4" ref-type="bibr">4</xref>). The SARS-CoV-2 infection has spread across the continents, as of March 25, 2021 a total of 125,429,834 cases with a mortality of 2,756,742 and recoveries of 101,293,629 are reported, based on the registered cases (
 <xref rid="B5" ref-type="bibr">5</xref>). Currently, quarantine, isolation, use of masks, physical distancing, washing of hands with soap water and symptomatic treatment protocol is being strictly followed to manage the disease, as there is no drug available till date to selectively target this virus. These data mainly highlight the extent of spread across the globe. Hence, finding prophylactic or therapeutic agents becomes important and essential.
</p>
